364 / 670
$2$& ,17(51$7,21$/
5 System Suitability Tests and/or Analytical Quality Control
6XLWDEOH PHWKRGV ZLOO LQFOXGH EODQN FKHFN VDPSOHV DQG FKHFN
VWDQGDUGV DW WKH ORZHVW SRLQW DQG PLGUDQJH SRLQW RI WKH DQDO\WLFDO
UDQJH 0HWKRGV PXVW EH FDSDEOH RI UHVROYLQJ OXWHLQ IURP ]HD[DQWKLQ
6 Reference Material(s)
1HLWKHU 1,67 QRU ,500 SURGXFH D FHUWL¿HG UHIHUHQFH PDWHULDO
IRU FDURWHQRLGV LQ LQIDQW IRUPXOD 7KH FDURWHQRLG FRQWHQW RI
650 D KDV QRW EHHQ GHWHUPLQHG DV RI 1RYHPEHU
7 Validation Guidance
5HFRPPHQGHG OHYHO RI YDOLGDWLRQ
Of¿cial Methods of
Analysis
60
8 Maximum Time-to-Result
1R PD[LPXP WLPH
Approved by Stakeholder Panel on Infant Formula and Adult
Nutritionals (SPIFAN). Final Version Date: September 6, 2014.
Effective Date: November 13, 2014.
7DEOH 0HWKRG SHUIRUPDQFH UHTXLUHPHQWV
a
3DUDPHWHU
0LQLPXP DFFHSWDEOH FULWHULD
$QDO\WLFDO UDQJH
±
b
/LPLW RI TXDQWLWDWLRQ
/24
b
5HFRYHU\
±
5HSHDWDELOLW\ 56'
U
±
! ±
5HSURGXFLELOLW\ 56'
5
±
! ±
a
&RQFHQWUDWLRQV DSSO\ WR
a
µUHDG\ WR IHHG´ OLTXLGV ³DV LV´
b
UHFRQVWLWXWHG SRZGHUV J LQWR J ZDWHU DQG
c
OLTXLG
FRQFHQWUDWHV GLOXWHG E\ ZHLJKW
b
ȝJ J UHFRQVWLWXWHG ¿QDO SURGXFW UDQJH DQG /24 DUH EDVHG RQ WRWDO
RI
cis trans
LVRPHUV